Spatially addressed combinatorial protein libraries for recombinant antibody discovery and optimization
Hongyuan Mao1, James J Graziano, Tyson M A Chase
1Fabrus LLC, La Jolla, California, USA.
Nature Biotechnology
|October 26, 2010
Summary
Researchers developed a novel antibody discovery method using small, de novo synthesized libraries. This approach screens protein libraries like small molecules, yielding optimized antibody drug leads with high specificity and affinity.
Area of Science:
- Biotechnology
- Protein Engineering
- Drug Discovery
Background:
- Traditional antibody discovery relies on hybridoma or display selection methods.
- These methods do not leverage the advantages of spatially addressed compound library screening used in small-molecule discovery.
Purpose of the Study:
- To adapt small-molecule screening strategies for antibody discovery.
- To demonstrate the efficacy of de novo synthesized antibody libraries for identifying potent protein drug leads.
Main Methods:
- Creation of a de novo DNA-synthesized library of approximately 10,000 human germline antibody fragments (Fabs).
- Automated protein expression and purification of the Fab library.
- Multiplexed screening assays to identify specific antibody binders against target antigens.
- Optimization of antibody binding affinities using sequence-activity relationships and iterative mutagenesis.
Main Results:
- Specific antibody hits were identified against seven out of nine tested antigens.
- Optimized Fabs achieved low nanomolar binding affinities.
- Matured Fabs demonstrated significant antagonism activity in cell-based assays.
Conclusions:
- Protein drug leads can be discovered efficiently using small, well-defined libraries.
- This method challenges the necessity for extremely large antibody libraries (billions of members).
- The approach integrates sequence, expression, and specificity data early in discovery, enabling functional screening and novel antibody development.
